OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002460 Ganfeng Lithium Group
- 33.97
- +0.14+0.41%
Trading Apr 1 13:23 CST
68.52BMarket Cap-33.04P/E (TTM)
34.20High33.72Low87.86KlotVolume33.83Open33.83Pre Close298.83MTurnover0.73%Turnover RatioLossP/E (Static)2.02BShares45.3052wk High1.64P/B41.06BFloat Cap24.9052wk Low37.21Limit Up1.21BShs Float158.27Historical High30.45Limit Down1.42%Amplitude-1.16Historical Low0.80Dividend TTM34.01Avg Price43.02KlotAsk2.36%Div YieldTTM100Lot Size43.28KlotBid
Ganfeng Lithium Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -42.66%18.91B | -45.78%13.93B | -47.16%9.59B | -46.41%5.06B | -21.16%32.97B | -6.99%25.68B | 25.63%18.15B | 75.91%9.44B | 274.68%41.82B | 291.45%27.61B |
| Operating revenue | -42.66%18.91B | -45.78%13.93B | -47.16%9.59B | -46.41%5.06B | -21.16%32.97B | -6.99%25.68B | 25.63%18.15B | 75.91%9.44B | 274.68%41.82B | 291.45%27.61B |
| Other operating revenue | 2.70%136.09M | ---- | 112.65%52.19M | ---- | 13.26%132.51M | ---- | -36.01%24.54M | ---- | 115.41%117M | ---- |
| Total operating cost | -37.15%19.78B | -37.03%14.7B | -33.18%10.28B | -16.63%5.54B | 34.10%31.47B | 68.96%23.34B | 126.07%15.39B | 188.04%6.64B | 198.62%23.47B | 162.53%13.81B |
| Operating cost | -40.76%16.86B | -41.21%12.48B | -39.18%8.55B | -19.78%4.74B | 34.76%28.46B | 74.45%21.23B | 146.68%14.06B | 230.59%5.92B | 214.36%21.12B | 167.74%12.17B |
| Operating tax surcharges | 39.26%114.84M | 25.78%67.86M | 30.41%41.92M | 26.90%18.41M | -77.91%82.47M | -74.31%53.95M | -67.59%32.14M | -57.64%14.51M | 323.68%373.28M | 372.17%210.03M |
| Operating expense | 31.59%146.85M | 34.74%102.61M | 38.20%68.39M | 42.02%42.49M | -4.91%111.6M | 8.96%76.15M | 21.89%49.49M | 158.47%29.92M | 90.45%117.36M | 84.60%69.89M |
| Administration expense | -11.30%871.38M | 26.92%831.26M | 52.06%570.53M | 102.27%304.85M | 5.26%982.42M | 28.31%654.98M | 5.85%375.21M | -31.23%150.72M | 98.54%933.29M | 79.88%510.48M |
| Financial expense | 50.22%873.51M | 38.77%526.8M | 164.33%589.09M | 50.48%209.41M | 797.44%581.48M | 477.51%379.61M | 182.72%222.86M | 251.25%139.16M | -145.81%-83.37M | -167.67%-100.56M |
| -Interest expense (Financial expense) | 39.07%1.09B | 35.57%768.53M | 47.93%506.78M | 39.43%235.73M | 92.55%784.31M | 105.08%566.89M | 75.95%342.58M | 148.14%169.06M | 53.79%407.33M | 40.69%276.43M |
| -Interest Income (Financial expense) | 14.08%-315.3M | 11.68%-231.62M | -7.17%-176.67M | -27.46%-84.78M | -85.90%-366.99M | -116.97%-262.24M | -125.19%-164.85M | -82.86%-66.52M | 4.88%-197.41M | -9.49%-120.86M |
| Research and development | -27.20%910.7M | -27.26%684.98M | -28.87%459.11M | -44.67%216.84M | 24.17%1.25B | -1.13%941.62M | 21.14%645.45M | 84.99%391.93M | 197.61%1.01B | 373.80%952.43M |
| Credit Impairment Loss | 20.08%-56.2M | 41.44%-34M | 70.30%-5.34M | 133.17%7.58M | -34.15%-70.32M | -266.11%-58.06M | -1,310.77%-17.97M | -1,576.94%-22.84M | -241.29%-52.42M | -105.18%-15.86M |
| Asset Impairment Loss | 74.21%-422.88M | 71.39%-272.43M | 89.98%-82.63M | 91.08%-105.2M | -2,440.08%-1.64B | -3,963.52%-952.15M | -15,278.42%-824.6M | -93,458.72%-1.18B | -706.56%-64.54M | -423.78%-23.43M |
| Other net revenue | -138.29%-1.42B | -104.16%-164.12M | -109.15%-312.93M | 95.31%-20.78M | -15.66%3.72B | 15.78%3.95B | 352.98%3.42B | -147.03%-443.03M | 82.51%4.41B | 230.77%3.41B |
| Fair value change income | -357.36%-1.48B | -187.70%-570.47M | -172.79%-873.89M | -274.78%-268.86M | 42.47%576.01M | 24.76%650.52M | 238.54%1.2B | -67.56%153.83M | -81.86%404.3M | -47.53%521.44M |
| Invest income | -96.94%101.42M | -87.02%430.65M | -84.79%381.55M | -54.44%258.86M | -17.06%3.31B | 16.28%3.32B | 58.60%2.51B | 28.15%568.16M | 4,203.35%4B | 15,030.77%2.85B |
| -Including: Investment income associates | -96.61%99.35M | -86.61%392.85M | -84.30%351.64M | -46.95%253.84M | -25.17%2.93B | 17.41%2.93B | 46.59%2.24B | 7.69%478.54M | 6,242.54%3.91B | 18,124.86%2.5B |
| Asset deal income | -313.36%-2.2M | -102.50%-34.64K | -98.14%5.2K | -81.59%-24.67K | -77.36%1.03M | -65.30%1.39M | 254.01%278.86K | ---13.59K | 1,786.65%4.55M | 1,776.76%3.99M |
| Other revenue | -71.45%438.6M | -71.53%282.17M | -51.77%267.37M | 131.50%86.87M | 1,180.82%1.54B | 1,261.60%990.93M | 1,087.40%554.31M | 53.05%37.53M | 85.55%119.94M | 133.29%72.78M |
| Operating profit | -144.00%-2.3B | -114.90%-937.19M | -116.29%-1.01B | -121.23%-499.75M | -77.08%5.22B | -63.44%6.29B | -26.38%6.18B | -41.17%2.35B | 298.03%22.76B | 509.57%17.21B |
| Add:Non operating Income | -80.97%11.03M | -85.94%7.9M | -90.81%5.07M | 4.69%922.9K | 55.77%57.95M | 57.80%56.21M | 63.45%55.22M | -97.24%881.58K | -44.29%37.2M | 5,350.64%35.62M |
| Less:Non operating expense | -6.41%16.39M | -14.09%9.97M | -54.78%4.29M | -12.33%958.02K | -16.81%17.51M | 9.62%11.61M | -4.54%9.48M | 1,085.00%1.09M | 73.94%21.05M | 36.35%10.59M |
| Total profit | -143.76%-2.3B | -114.83%-939.26M | -116.15%-1.01B | -121.23%-499.78M | -76.91%5.26B | -63.24%6.34B | -26.04%6.22B | -41.64%2.35B | 294.54%22.78B | 512.00%17.23B |
| Less:Income tax cost | -51.85%329.06M | -79.64%92.83M | -83.98%60.52M | -49.48%95.87M | -70.52%683.47M | -79.70%455.97M | -64.57%377.64M | -59.91%189.78M | 549.34%2.32B | 718.81%2.25B |
| Net profit | -157.49%-2.63B | -117.55%-1.03B | -118.23%-1.07B | -127.53%-595.65M | -77.64%4.58B | -60.77%5.88B | -20.46%5.85B | -39.21%2.16B | 277.74%20.46B | 489.68%14.99B |
| Net profit from continuing operation | -157.49%-2.63B | -117.55%-1.03B | -118.23%-1.07B | -127.53%-595.65M | -77.64%4.58B | -60.77%5.88B | -20.46%5.85B | -39.21%2.16B | 277.74%20.46B | 489.68%14.99B |
| Less:Minority Profit | -49.71%-556.25M | -200.50%-391.7M | -8,805.14%-305.66M | 32.62%-156.75M | -765.09%-371.56M | -167.78%-130.35M | -103.55%-3.43M | -765.72%-232.63M | -122.83%-42.95M | 179.56%192.32M |
| Net profit of parent company owners | -141.93%-2.07B | -110.66%-640.39M | -113.00%-760.38M | -118.31%-438.9M | -75.87%4.95B | -59.38%6.01B | -19.35%5.85B | -32.01%2.4B | 292.16%20.5B | 498.31%14.79B |
| Earning per share | ||||||||||
| Basic earning per share | -141.87%-1.03 | -110.74%-0.32 | -113.10%-0.38 | -118.49%-0.22 | -75.83%2.46 | -59.46%2.98 | -19.44%2.9 | -32.00%1.19 | 281.27%10.18 | 315.25%7.35 |
| Diluted earning per share | -141.87%-1.03 | -110.74%-0.32 | -113.10%-0.38 | -118.49%-0.22 | -75.81%2.46 | -59.35%2.98 | -19.44%2.9 | -32.00%1.19 | 282.33%10.17 | 314.12%7.33 |
| Other composite income | -16.36%448.93M | -137.14%-349.11M | -82.49%197.92M | 114.95%48.92M | -62.70%536.77M | -51.27%939.97M | 34.33%1.13B | -91.87%-327.12M | 574.80%1.44B | 1,697.85%1.93B |
| Other composite income of parent company owners | -14.99%419.83M | -140.33%-347.37M | -82.81%177.48M | 115.28%44.73M | -58.96%493.89M | -47.43%861.24M | 47.95%1.03B | -71.75%-292.82M | 585.80%1.2B | 3,617.80%1.64B |
| Other composite income of minority owners | -32.15%29.1M | -102.21%-1.74M | -79.02%20.43M | 112.20%4.19M | -81.81%42.88M | -72.90%78.73M | -32.02%97.41M | ---34.31M | 525.61%235.71M | 88.80%290.48M |
| Total composite income | -142.67%-2.18B | -120.25%-1.38B | -112.44%-868.12M | -129.76%-546.73M | -76.66%5.11B | -59.69%6.82B | -14.83%6.98B | -45.81%1.84B | 328.27%21.9B | 538.61%16.92B |
| Total composite income of parent company owners | -130.40%-1.65B | -114.38%-987.75M | -108.47%-582.89M | -118.74%-394.17M | -74.94%5.44B | -58.19%6.87B | -13.44%6.88B | -37.29%2.1B | 335.82%21.71B | 577.31%16.43B |
| Total composite income of minority owners | -60.38%-527.15M | -662.14%-393.44M | -403.51%-285.23M | 42.85%-152.56M | -270.52%-328.68M | -110.69%-51.62M | -60.85%93.98M | -863.90%-266.93M | 45.19%192.76M | 116.84%482.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.